TickerFacts.

Drugs Made In America Acquisition Corp. (DMAA): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$7.26M
As of 2025-12-31
-$7.41M
As of 2026-06-30
2024-12-31: -$244.8K2025-12-31: -$7.26M-$7.26M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$7.26Mn/m2026-04-15, Balance as of period end
2024-12-31-$244.8Kn/a2026-04-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Drugs Made In America Acquisition Corp. (DMAA)2025-12-31-$7.26Mn/m
Fifth Era Acquisition Corp I (FERA)2025-12-31-$13.33Mn/m
Archimedes Tech SPAC Partners II Co. (ATII)2025-12-31-$6.70Mn/m
Roman DBDR Acquisition Corp. II (DRDB)2025-12-31-$778.1Kn/m
Sizzle Acquisition Corp. II (SZZL)2025-12-31-$10.13Mn/m
Evolution Global Acquisition Corp (EVOX)2025-12-31-$8.50Mn/a
Cal Redwood Acquisition Corp. (CRAQ)2025-12-31-$8.14Mn/a
Rithm Acquisition Corp. (RAC)2025-09-30-$7.22Mn/a
Jackson Acquisition Co II (JACS)2025-12-31$220.8K-72.1%

Compare DMAA, FERA, ATII, DRDB side by side · Screen every company in Blank Checks ↗